Yes, but the question is whether it would be sold cheaply in relation to its potential.
we can't answer that question at this point in time, but if you have that thought in your head, then if this drug outgrows that valuation, you'll potentially be short changed.
I think better to let the share price increase organically, use wombat's guidelines, and be patient to see where this all takes us. Who knows, pillars may fail and it may be much less, but no one will complain if we get a great deal, we will only lament if we get a bad one.
Yes, but the question is whether it would be sold cheaply in...
-
- There are more pages in this discussion • 17,798 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
-0.095(5.44%) |
Mkt cap ! $281.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.62 | $285.9K | 170.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16759 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 12047 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |